REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,934,599 | +6.8% | 9,643,591 | +3.2% | 0.01% | +16.7% |
| Q2 2023 | $249,858,456 | +24.0% | 9,340,503 | +0.4% | 0.01% | +20.0% |
| Q1 2023 | $201,493,299 | +11.9% | 9,302,553 | +23.0% | 0.01% | 0.0% |
| Q4 2022 | $180,124,696 | +30.8% | 7,561,910 | +8.3% | 0.01% | +25.0% |
| Q3 2022 | $137,725,000 | +26.9% | 6,984,002 | +25.5% | 0.00% | +33.3% |
| Q2 2022 | $108,502,000 | -29.8% | 5,567,012 | -8.1% | 0.00% | -25.0% |
| Q1 2022 | $154,538,000 | -2.5% | 6,057,931 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $158,562,000 | -7.6% | 6,299,609 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $171,668,000 | +2.7% | 6,240,198 | +18.4% | 0.00% | 0.0% |
| Q2 2021 | $167,224,000 | -24.9% | 5,268,564 | +8.6% | 0.00% | -33.3% |
| Q1 2021 | $222,530,000 | +39.2% | 4,850,262 | +20.1% | 0.01% | +20.0% |
| Q4 2020 | $159,858,000 | +33.1% | 4,037,820 | +17.0% | 0.01% | +25.0% |
| Q3 2020 | $120,064,000 | +188.4% | 3,450,101 | +161.6% | 0.00% | +300.0% |
| Q2 2020 | $41,634,000 | +74.4% | 1,318,767 | +21.0% | 0.00% | 0.0% |
| Q1 2020 | $23,875,000 | – | 1,089,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |